ONCORUS INC (ONCR) Stock Price, Quote, News and Overview
NASDAQ:ONCR - Nasdaq - US68236R1032 - Common Stock - Currency: USD
ONCR Quote, Performance and Key Statistics
NASDAQ:ONCR (6/20/2023, 8:14:14 PM)
0.1206
-0.01 (-8.5%)
The current stock price of ONCR is 0.1206 USD. In the past month the price decreased by -60.83%. In the past year, price decreased by -91.45%.
ONCR Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 19.97 | 357.10B | ||
| AMGN | AMGEN INC | 15.29 | 162.72B | ||
| GILD | GILEAD SCIENCES INC | 23.85 | 137.00B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 1669.79 | 124.40B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.34 | 76.56B | ||
| ARGX | ARGENX SE - ADR | N/A | 39.16B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 32.32B | ||
| BNTX | BIONTECH SE-ADR | N/A | 28.77B | ||
| ONC | BEIGENE LTD-ADR | N/A | 27.25B | ||
| NTRA | NATERA INC | N/A | 21.43B | ||
| BIIB | BIOGEN INC | 8.54 | 20.49B | ||
| SMMT | SUMMIT THERAPEUTICS INC | N/A | 16.31B |
Related stock screener links
About ONCR
Company Profile
Oncorus, Inc. engages in the research and development of a viral immunotherapy platform. The company is headquartered in Andover, Massachusetts and currently employs 64 full-time employees. The company went IPO on 2020-10-02. The Company’s two product candidates from its self-amplifying RNA platform are ONCR-021 and ONCR-788. ONCR-021, a lead product candidate that is an IV administered viral RNA encoding an optimized genome of Coxsackievirus 21A (CVA21), is encapsulated within a lipid nanoparticle (LNP). The firm intends to develop ONCR-021 for non-small cell lung cancer, renal cell carcinoma, melanoma, anaplastic thyroid cancer, and hepatocellular carcinoma. The firm is also developing ONCR-788, which encodes for a modified version of the Seneca Valley Virus (SVV). The firm designed its HSV platform, including product candidate ONCR-719, to overcome the limitations in potency and in the ability to stimulate anti-tumor immunity that have both been encountered by previous viral immunotherapies and other immuno-oncology therapies.
Company Info
ONCORUS INC
4 Corporate Drive
Andover MASSACHUSETTS 02139 US
CEO: Theodore (Ted) Ashburn
Employees: 64
Company Website: https://mpmcapital.com/
Phone: 18573206400.0
ONCORUS INC / ONCR FAQ
What is the stock price of ONCORUS INC today?
The current stock price of ONCR is 0.1206 USD. The price decreased by -8.5% in the last trading session.
What is the ticker symbol for ONCORUS INC stock?
The exchange symbol of ONCORUS INC is ONCR and it is listed on the Nasdaq exchange.
On which exchange is ONCR stock listed?
ONCR stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for ONCORUS INC stock?
7 analysts have analysed ONCR and the average price target is 5.1 USD. This implies a price increase of 4128.86% is expected in the next year compared to the current price of 0.1206. Check the ONCORUS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is ONCORUS INC worth?
ONCORUS INC (ONCR) has a market capitalization of 3.15M USD. This makes ONCR a Nano Cap stock.
How many employees does ONCORUS INC have?
ONCORUS INC (ONCR) currently has 64 employees.
Should I buy ONCORUS INC (ONCR) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of ONCR, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of ONCR, evaluating the profitability, health, valuation and growth aspects
- ONCORUS INC (ONCR) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- ONCORUS INC (ONCR) Sales and EPS estimates to see what analysts future expectations are.
- ONCORUS INC (ONCR) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- ONCORUS INC (ONCR) Insider and Institutional Ownership to learn about the owners and their transactions.
- ONCORUS INC (ONCR) Stock Chart to make your own analysis
- ONCORUS INC (ONCR) Latest news and press-releases to stay up to date.
Does ONCORUS INC (ONCR) stock pay dividends?
ONCR does not pay a dividend.
When does ONCORUS INC (ONCR) report earnings?
ONCORUS INC (ONCR) will report earnings on 2023-08-02, before the market open.
What is the Price/Earnings (PE) ratio of ONCORUS INC (ONCR)?
ONCORUS INC (ONCR) does not have a PE ratio as the earnings reported over the last twelve months were negative (-3.49).
ONCR Technical Analysis
ONCR Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to ONCR. ONCR may be in some trouble as it scores bad on both profitability and health.
ONCR Financial Highlights
Over the last trailing twelve months ONCR reported a non-GAAP Earnings per Share(EPS) of -3.49. The EPS decreased by -28.78% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | 0 |
ONCR Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 46% to ONCR. The Buy consensus is the average rating of analysts ratings from 7 analysts.